Polaris Venture Management Co. V as of June 30, 2019
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 12 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cardlytics (CDLX) | 46.5 | $59M | 2.3M | 25.98 | |
| Fate Therapeutics (FATE) | 23.5 | $30M | 1.5M | 20.30 | |
| Kala Pharmaceuticals | 9.3 | $12M | 1.9M | 6.38 | |
| Neuronetics (STIM) | 7.3 | $9.3M | 742k | 12.51 | |
| Selecta Biosciences | 3.9 | $5.0M | 2.8M | 1.79 | |
| X4 Pharmaceuticals (XFOR) | 3.7 | $4.7M | 312k | 15.00 | |
| T2 Biosystems | 2.4 | $3.1M | 1.8M | 1.68 | |
| Trevena | 1.7 | $2.1M | 2.1M | 1.03 | |
| Genocea Biosciences (GNCAQ) | 0.8 | $965k | 246k | 3.92 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.5 | $670k | 131k | 5.13 | |
| Pulmatrix | 0.3 | $331k | 359k | 0.92 | |
| Dare Bioscience | 0.2 | $277k | 326k | 0.85 |
